PL2275441T3 - Receptory komórek T o wysokim powinowactwie dla HIV - Google Patents

Receptory komórek T o wysokim powinowactwie dla HIV

Info

Publication number
PL2275441T3
PL2275441T3 PL10008612T PL10008612T PL2275441T3 PL 2275441 T3 PL2275441 T3 PL 2275441T3 PL 10008612 T PL10008612 T PL 10008612T PL 10008612 T PL10008612 T PL 10008612T PL 2275441 T3 PL2275441 T3 PL 2275441T3
Authority
PL
Poland
Prior art keywords
high affinity
cell receptors
affinity hiv
hiv
receptors
Prior art date
Application number
PL10008612T
Other languages
English (en)
Inventor
Bent Karsten Jakobsen
Peter Eamon Molloy
Yi Li
Steven Mark Dunn
Original Assignee
Immunocore Ltd.
Adaptimmune Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0506760A external-priority patent/GB0506760D0/en
Priority claimed from GB0516487A external-priority patent/GB0516487D0/en
Application filed by Immunocore Ltd., Adaptimmune Limited filed Critical Immunocore Ltd.
Publication of PL2275441T3 publication Critical patent/PL2275441T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
PL10008612T 2005-04-01 2006-03-29 Receptory komórek T o wysokim powinowactwie dla HIV PL2275441T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0506760A GB0506760D0 (en) 2005-04-01 2005-04-01 High affinity HIV TCRS
GB0516487A GB0516487D0 (en) 2005-08-10 2005-08-10 High affinity HIV T cell receptors
EP10008612.3A EP2275441B8 (en) 2005-04-01 2006-03-29 High affinity HIV T cell receptors

Publications (1)

Publication Number Publication Date
PL2275441T3 true PL2275441T3 (pl) 2017-07-31

Family

ID=37053744

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10008612T PL2275441T3 (pl) 2005-04-01 2006-03-29 Receptory komórek T o wysokim powinowactwie dla HIV

Country Status (16)

Country Link
US (2) US8378074B2 (pl)
EP (4) EP1863842A2 (pl)
JP (3) JP2008535826A (pl)
CN (2) CN105461802A (pl)
AU (1) AU2006228308B2 (pl)
CA (1) CA2602463C (pl)
CY (1) CY1118160T1 (pl)
DK (1) DK2275441T3 (pl)
ES (2) ES2599010T3 (pl)
HU (1) HUE032037T2 (pl)
LT (1) LT2275441T (pl)
NZ (2) NZ561338A (pl)
PL (1) PL2275441T3 (pl)
PT (1) PT2275441T (pl)
SI (1) SI2275441T1 (pl)
WO (1) WO2006103429A2 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040191260A1 (en) 2003-03-26 2004-09-30 Technion Research & Development Foundation Ltd. Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
AU2003216341A1 (en) 2002-02-20 2003-09-09 Dyax Corporation Mhc-peptide complex binding ligands
WO2006036445A2 (en) 2004-09-24 2006-04-06 Trustees Of Dartmouth College Chimeric nk receptor and methods for treating cancer
WO2008042814A2 (en) * 2006-09-29 2008-04-10 California Institute Of Technology Mart-1 t cell receptors
JP5292550B2 (ja) * 2007-03-23 2013-09-18 静岡県 Ｔ細胞レセプターβ鎖遺伝子及びα鎖遺伝子
EP2280731A1 (en) 2008-04-09 2011-02-09 Technion Research and Development Foundation, Ltd. Anti human immunodeficiency antibodies and uses thereof
GB0816096D0 (en) * 2008-09-04 2008-10-15 Medigene Ltd Diabetes t cell receptors
EP2411545B1 (en) * 2009-03-25 2017-03-08 Altor BioScience Corporation Hiv vpr-specific t cell receptors
WO2011044186A1 (en) * 2009-10-06 2011-04-14 The Board Of Trustees Of The University Of Illinois Human single-chain t cell receptors
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
WO2011059836A2 (en) 2009-10-29 2011-05-19 Trustees Of Dartmouth College T cell receptor-deficient t cell compositions
US12492376B2 (en) 2009-10-29 2025-12-09 The Trustees Of Dartmouth College T-cell receptor-deficient T cell compositions
GB201016672D0 (en) 2010-10-04 2010-11-17 Electronic Shipping Solutions Ltd Secure exchange/authentication of electronic documents
EP2502934B1 (en) * 2011-03-24 2018-01-17 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Single chain antigen recognizing constructs (scARCs) stabilized by the introduction of novel disulfide bonds
WO2013033626A2 (en) 2011-08-31 2013-03-07 Trustees Of Dartmouth College Nkp30 receptor targeted therapeutics
CN110511278B (zh) 2012-05-07 2024-08-09 达特茅斯大学理事会 抗b7-h6抗体、融合蛋白及其使用方法
SG11201500423TA (en) * 2012-07-27 2015-02-27 Univ Illinois Engineering t-cell receptors
EP4609876A2 (en) 2014-05-29 2025-09-03 The United States of America, as represented by the Secretary, Department of Health and Human Services Anti-human papillomavirus 16 e7 t cell receptors
CA2955984A1 (en) 2014-07-22 2016-01-28 The University Of Notre Dame Du Lac Molecular constructs and uses thereof
NL2014935B1 (en) 2015-06-08 2017-02-03 Applied Immune Tech Ltd T cell receptor like antibodies having fine specificity.
GB201516272D0 (en) 2015-09-15 2015-10-28 Adaptimmune Ltd And Immunocore Ltd TCR Libraries
GB201516277D0 (en) * 2015-09-15 2015-10-28 Adaptimmune Ltd And Immunocore Ltd TCR libraries
EP3211003A1 (en) * 2016-02-24 2017-08-30 Institut Pasteur T cell receptors from the hiv-specific repertoire, means for their production and therapeutic uses thereof
GB201604953D0 (en) 2016-03-23 2016-05-04 Immunocore Ltd T cell receptors
US11505590B2 (en) 2016-04-08 2022-11-22 Immunocore Limited T cell receptors
DE102017115966A1 (de) * 2017-07-14 2019-01-17 Immatics Biotechnologies Gmbh Polypeptidmolekül mit verbesserter zweifacher Spezifität
LT3652215T (lt) 2017-07-14 2021-05-25 Immatics Biotechnologies Gmbh Pagerinta dvejopo savitumo polipeptido molekulė
EP3806961A4 (en) 2018-05-11 2022-10-19 Memorial Sloan Kettering Cancer Center T LYMPHOCYTE RECEPTORS TARGETING PIK3CA MUTATIONS AND THEIR USES
US20210371849A1 (en) * 2018-07-31 2021-12-02 Janux Therapeutics, Inc. Inhibitory t cell receptor peptides and discovery methods
US12234473B2 (en) 2020-12-31 2025-02-25 Immatics US, Inc. CD8 polypeptides, compositions, and methods of using thereof
US12103971B2 (en) 2022-02-20 2024-10-01 Immunocore Limited HIV specific binding molecules
AU2023222190A1 (en) * 2022-02-20 2024-08-29 Immunocore Limited Hiv-specific binding molecules and tcr
IL319060A (en) 2022-08-18 2025-04-01 Immunocore Ltd MAGE A4-specific T-cell receptor fusion proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759243B2 (en) * 1998-01-20 2004-07-06 Board Of Trustees Of The University Of Illinois High affinity TCR proteins and methods
PL364734A1 (pl) * 1998-05-19 2004-12-13 Avidex Limited Rozpuszczalny receptor komórek T
WO2003020763A2 (en) * 2001-08-31 2003-03-13 Avidex Limited Soluble t cell receptor
US7751825B2 (en) 2002-06-27 2010-07-06 Qualcomm Incorporated Controlling geographic location information of devices operating in wireless communication systems
NZ539225A (en) 2002-10-09 2006-09-29 Avidex Ltd Single chain recombinant T cell receptors
NZ539226A (en) * 2002-11-09 2008-09-26 Medigene Ltd T cell receptor display
EP1756278B1 (en) * 2004-05-19 2008-09-17 MediGene Ltd. Method of improving t cell receptors

Also Published As

Publication number Publication date
AU2006228308A1 (en) 2006-10-05
CA2602463A1 (en) 2006-10-05
LT2275441T (lt) 2016-12-12
EP2985291B1 (en) 2018-09-19
PT2275441T (pt) 2016-11-18
US20130295063A1 (en) 2013-11-07
WO2006103429A2 (en) 2006-10-05
EP2275441A1 (en) 2011-01-19
EP2275441B8 (en) 2016-10-19
CY1118160T1 (el) 2017-06-28
CN103059128B (zh) 2016-01-20
EP2275441B1 (en) 2016-08-24
EP2301964A1 (en) 2011-03-30
ES2599010T3 (es) 2017-01-31
AU2006228308B2 (en) 2012-05-17
JP2012144543A (ja) 2012-08-02
JP5612623B2 (ja) 2014-10-22
JP2014205671A (ja) 2014-10-30
US8378074B2 (en) 2013-02-19
SI2275441T1 (sl) 2016-11-30
CN105461802A (zh) 2016-04-06
NZ584523A (en) 2010-11-26
EP2985291A1 (en) 2016-02-17
WO2006103429A3 (en) 2007-03-15
US20090214551A1 (en) 2009-08-27
JP5885220B2 (ja) 2016-03-15
NZ561338A (en) 2010-04-30
ES2699320T3 (es) 2019-02-08
EP1863842A2 (en) 2007-12-12
DK2275441T3 (en) 2016-12-12
CN103059128A (zh) 2013-04-24
EP2275441A9 (en) 2011-09-14
HUE032037T2 (en) 2017-08-28
US9255135B2 (en) 2016-02-09
CA2602463C (en) 2018-09-04
JP2008535826A (ja) 2008-09-04

Similar Documents

Publication Publication Date Title
PL2275441T3 (pl) Receptory komórek T o wysokim powinowactwie dla HIV
ZA200710009B (en) High affinity melan-AT cell receptors
GB2423490B (en) Separator
GB2424118B (en) Fuel cells
GB0714133D0 (en) Invoice hnancing
ZA200708037B (en) High affinity HIV T cell receptors
GB0600575D0 (en) Electrode
EP1953858A4 (en) FUEL CELL
EP1976047A4 (en) FUEL CELL
EP1970988A4 (en) FUEL CELL
GB0503918D0 (en) Cell
EP1897159A4 (en) LEAD-ALKALI BATTERY
EP1923943A4 (en) COMPONENT FOR CONSTITUTING A FUEL CELL
IL187217A0 (en) Cell nucleus-entering compositions
GB0516487D0 (en) High affinity HIV T cell receptors
GB0516079D0 (en) Separator
GB0500073D0 (en) Electrochemical electrode
GB2445900B (en) Mobile structure for adapting surfaces
GB0522564D0 (en) Cells
GB0411772D0 (en) High affinity telomerase t cell receptors
GB0419644D0 (en) High affinity telomerase t cell receptors
GB0526629D0 (en) Conference folder lapdesk
GB0419643D0 (en) High affinity ny-eso t cell receptors
GB0523023D0 (en) Electrode separatror
GB0510475D0 (en) Electrode